Santen SAS

Industry · 14 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group Primary Open Angle Glaucoma	—	2026-03-01
Recruiting	Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life. Myopia	—	2025-07-29
Recruiting	LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Sin Acquired Blepharophimosis	Phase 3	2024-12-30
Completed	3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconj Dry Eye Syndromes	N/A	2021-09-30
Active Not Recruiting	3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjuncti Dry Eye Syndromes	N/A	2021-05-11
Completed	3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin) Dry Eye Disease With Severe Keratitis	Phase 3	2019-05-31
Completed	A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Eff Open-Angle Glaucoma or Ocular Hypertension, Ocular Surface Disease	Phase 3	2019-04-10
Completed	Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Kerat Keratitis	Phase 4	2017-03-28
Completed	Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With A Vernal Keratoconjunctivitis	Phase 3	2013-04-29
Completed	Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Glaucoma, Ocular Hypertension, Ocular Surface Disease	Phase 2	2010-11-01
Completed	NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye Dry Eye	Phase 2	2008-08-01
Completed	Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Dia Diabetic Macular Edema	Phase 1	2008-04-01
Completed	Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Moderate to Severe Dry Eye Syndrome	Phase 3	2007-09-01
Completed	Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) Conjunctivitis, Vernal	Phase 2 / Phase 3	2006-05-01